Risk factors for the development of post-endoscopic retrograde cholangiopancreatography pancreatitis in patients with asymptomatic common bile duct stones

doi:10.4253/wjge.v11.i10.515

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6056)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-3) series.

Item

Count

PDF

419

WORD

150

HTML

2574

Tables (1-3)

347

Sum=3490

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

787

Download

1779

Sum=2566

Oct 16, 2019 (publication date) through Apr 7, 2025

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Endoscopy

ISSN

1948-5190

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Endosc. Oct 16, 2019; 11(10): 515-522
Published online Oct 16, 2019. doi: 10.4253/wjge.v11.i10.515

Table 1 The characteristics of 168 asymptomatic patients

Characteristics	n (%)
Age [mean (SD)], yr	72.6 (11.2)
Sex, female	77 (45.8)
Billroth I reconstruction	9 (5.4)
Non-dilated CBD (< 10 mm)	99 (58.9)
Pharmacological prevention	82 (48.8)
Protease inhibitor	67 (39.9)
Rectal NSAIDs	15 (8.9)
Trainee endoscopist	39 (23.2)
Pancreatic injections	88 (52.4)
PGW-assisted cannulation	33 (19.6)
Precut sphincterotomy	15 (8.9)
Cannulation time > 10 min	64 (38.1)
Unsuccessful cannulation	4 (2.4)
EST	146 (86.9)
EPBD	14 (8.3)
EPLBD	4 (2.4)
Prophylactic pancreatic stent	27 (16.1)
Procedure time [mean (SD)], min	31.1 (16.4)

CBD: Common bile duct; NSAIDs: Nonsteroidal anti-inflammatory drugs; PGW: Pancreatic guide wire; EST: Endoscopic sphincterotomy; EPBD: Endoscopic papillary balloon dilation; EPLBD: Endoscopic papillary large balloon dilation.

Citation: Saito H, Kakuma T, Matsushita I. Risk factors for the development of post-endoscopic retrograde cholangiopancreatography pancreatitis in patients with asymptomatic common bile duct stones. World J Gastrointest Endosc 2019; 11(10): 515-522
URL: https://www.wjgnet.com/1948-5190/full/v11/i10/515.htm
DOI: https://dx.doi.org/10.4253/wjge.v11.i10.515